Evidence map›Paper›PMID 40177911›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025

Combination of rhinoshave and fractional ablative CO

Conrad Hempel, Anna-Theresa Seitz, Viktor Schnabel, Till Mittank-Weidner, Jan-Christoph Simon, Sonja Grunewald

Abstract read
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Combination of rhinoshave and fractional ablative COJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Conrad HempelClinic and Polyclinic for Dermatology, Venereology and Allergology, Leipzig University Hospital, Leipzig, Germany.
Anna-Theresa SeitzClinic and Polyclinic for Dermatology, Venereology and Allergology, Leipzig University Hospital, Leipzig, Germany.
Viktor SchnabelClinic and Polyclinic for Dermatology, Venereology and Allergology, Leipzig University Hospital, Leipzig, Germany.
Till Mittank-WeidnerClinic and Polyclinic for Dermatology, Venereology and Allergology, Leipzig University Hospital, Leipzig, Germany.
Jan-Christoph SimonClinic and Polyclinic for Dermatology, Venereology and Allergology, Leipzig University Hospital, Leipzig, Germany.
Sonja GrunewaldClinic and Polyclinic for Dermatology, Venereology and Allergology, Leipzig University Hospital, Leipzig, Germany.ORCID 0000-0002-2165-6274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrently, there are no effective drug therapy options that lead to the regression of rhinophyma. Many surgical procedures for treating rhinophyma have been published; however, there are limited data on their effectiveness. In addition, these treatment options often lead to persistent hypopigmented scarring if excessive ablation or heat is applied. PATIENTS AND

methodsTo prevent excessively deep ablation and enable precise nasal contouring, a combination therapy was developed, integrating classic rhinoshave for coarse ablation followed by laser fine contouring. Fractional ablation was performed to minimize heat accumulation. Here, we report on 45 patients with pronounced rhinophyma who underwent this treatment at the Dermatology Clinic of Leipzig University between 2016 and 2024. The median follow-up period was 51 months (range: 6-96 months).

resultsThe majority of the patients were either very satisfied or satisfied with the postoperative outcome (n = 26; 92.3%). One case of postoperative hemorrhage was reported (2.2%). There was no wound infection observed, and the recurrence rate was 17.9%.

conclusionsThe combination of rhinoshave and fractional ablative CO

Indexed as

Lasers, GasLaser TherapyRhinophymaAdultAgedCombined Modality TherapyFemaleFollow-Up StudiesHumansMaleMiddle AgedPatient SatisfactionRetrospective StudiesTreatment OutcomeYoung AdultCO2 laser treatmentRhinophymashave excisionskin surgery

Identifiers

PMID40177911
PMCPMC12257053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.